Miriam Nofarber's Contact Details

Miriam Nofarber's Company Details

Pharma14.com

Herzliya, Tel Aviv District, Israel • 9 Employees
Pharmaceuticals

Pharma14 is a leading global medicine database platform used by a wide spectrum of life science companies. Our monthly updated platform is used by governmental agencies, pharmaceutical companies, consultants, CMO's, API manufacturers, wholesalers and pharmacy retail chains. Pharma14's robust and accurate medicine data, as well as its industry leading drug pricing reimbursement information give its members the tools required to compete in today's market. Key pricing drivers such as generics, parallel trade, biosimillars, niche markets and more provide unique industry insight.Pharma14 can help you.Track and analyze pricing and reimbursement environments.Find and create your optimal product launch pricing.Track historical price movement.Live track first generics entering the market and create future strategy for loss of exclusivity.Navigate dossier submission landscape.Enter price negotiations with full information.Create and track your own IRP (International Reference Price) data.Seek out niche markets and products.Track consumption and sale trends.HIGHLIGHTS:Pharma14 full highlights:• 60 full country medicine database. https://www.pharma14.com/StaticPages/Features• 2,500,000 medicines (Rx and OTC) - full information about each drug including - Ex-factory, Wholesale and retail prices + reimbursed information.• First approval date and marketing authorizations for all molecules from USA, Europe.• Standard monthly updates.• Full European parallel import information.• Excel downloads.• Niche market product locator.• Active ingredients, ATC code classification, administration routes, strength, trade names, MA holder information, leaflets in PDF format and much more.• Real manufacturer information.• Consumption and sales data for USA, Germany, UK, France, Italy, Scandinavia, Baltics, Canada, Hungary and more.• Market Opportunity Locator business tool. Live track the molecules with the least competition per country.• Live track first generic reg.